AN ANALYSIS OF CLINICAL, DEMOGRAPHIC CHARACTERISTICS AND COSTS OF ACUTE COPD EXACERBATION PATIENTS ADMITTED TO OUR EMERGENCY DEPARTMENT
Aim: Our study aimed to determine the demographic factors affecting the hospital costs of patients with COPD exacerbation.
Methods: The study was retrospectively conducted on patients, who presented to the Department of Emergency Medicine of Abant Izzet Baysal University with the complaints of COPD exacerbation between 01.06.2016 - 30.06.2017. The correlation between age, gender, occupations, places of residence, levels of education, history of smoking, methods of heating, comorbidities, times of application, symptoms, vital findings and findings of physical examination, blood gas results, frequency of admission to emergency department, frequency of hospitalization, emergency department outcomes of all patients and the cost was analyzed.
Results: The median age of the patients was 73 years, and 76.8% of them were male. The median cost of the patients was TRY 136.8. There was no correlation between the cost and gender, employment status, place of residence, level of education, duration of smoking, type of medicines used at home, and method of heating (p>0.05). The costs of the patients who were admitted in the spring months were significantly lower compared to those who were admitted in other seasons (p>0.05). It was found that the cost was not increased by the presence of comorbidities, HT, CHF, and DM (p>0.05). It was found that the cost increased significantly as the general condition worsened (p>0.05). It was determined that the cost was positively correlated with respiratory rate and negatively correlated with DKS (p>0.05). The cost was found to be significantly higher in patients with extrapulmonary examination findings (p>0.05). HCO3 and cost were found to be negatively correlated (p<0.05). No correlation was found between the cost and the frequency of admission to emergency department and hospitalization of the patients (p>0.05). The costs of the patients, who were admitted to intensive care or ward, were significantly higher (p>0.05).
Conclusion: The cost is affected by a number of factors in patients admitted due to COPD exacerbation, the most important factor affecting the cost is patient’s clinic. Poor patient clinic determines both the treatment to be provided in the emergency department and the status of hospitalization.
Yakup Kale1, Cemil Kavalcı2, Tamer Çolak1,
Kaan Çelik1, Beliz Öztok Tekten1
1 Bolu Abant Izzet Baysal University Faculty of Medicine, Emergency department, Turkey;
2 SB Dışkapı Yıldırım Beyazıt Training and Research Hospital, Emergency department, Turkey.
1. Fabbri L.M., Hurd S. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respiratory Soc 2003;22:1 doi: 10.1183/09031936.03.00063703
2. Erdinç E., Polatlı M., Kocabaş A. Türk Toraks Derneği kronik obstrüktif akciğer hastalığı tanı ve tedavi uzlaşı raporu. Türk Toraks Dergisi. 2010;11:5-11.
3. Garcia-Aymerich J., Farrero E., Felez M., Izquierdo J., Marrades R., Anto J. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100-5.
4. Katz P.P., Eisner M.D., Yelin E.H., Trupin L., Earnest G., Balmes J., et al. Functioning and psychological status among individuals with COPD. Quality of Life Research. 2005;14(8):1835-43.
5. Williams V., Bruton A., Ellis-Hill C., McPherson K. What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chronic Respiratory Disease. 2007;4(2):77-85.
6. Hasson F., Spence A., Waldron M., Kernohan G., McLaughlin D., Watson B., et al. I can not get a breath: experiences of living with advanced chronic obstructive pulmonary disease. International journal of palliative nursing. 2008;14(11):526-31.
7. Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. Journal of pain and symptom management. 2008;36(5):451-60.
8. Spruit M.A., Troosters T., Trappenburg J.C., Decramer M., Gosselink R. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient education and counseling. 2004;52(3):243-8.
9. Perera P.N., Armstrong E.P., Sherrill D.L., Skrepnek G.H. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2012;9(2):131-41.
10. Chen Y.-h., Yao W-z, Cai B-q, Wang H, Deng X-m, Gao H-l, et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chinese medical journal. 2008;121(7):587-91.
11. Rutten-van Mölken M., Postma M., Joore M., Van Genugten M., Leidl R., Jager J. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respiratory medicine. 1999;93(11):779-87.
12. Jacobson L., Hertzman P., Löfdahl C.-G., Skoogh B., Lindgren B. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991. Respiratory medicine. 2000;94(3):247-55.
13. Friedman M., Hilleman D.E. Economic burden of chronic obstructive pulmonary disease. Pharmacoeconomics. 2001;19(3):245-54.
14. Tülüce D., Kutlutürkan S. An effıcıent approach to care cost effectıveness ın patıents dıagnosed wıth stable COPD: Patıent coachıng Stabil KOAH tanılı hastalarda bakım maliyet etkinliği üzerine etkili bir yaklaşım: Hasta koçluğu. Journal of Human Sciences. 2016;13(2):2697-709.
15. Özdemir T., Aydın L., Türkkanı M., Kılıç T. KOAH Hastaları Hastaneden Çıkmıyor mu? Ankara Medikal Journal 2015;15(1):6-9
16. Bustacchini S., Chiatti C., Furneri G., Lattanzio F., Mantovani L.G. The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature. Current opinion in pulmonary medicine. 2011;17:S35-S41.
17. Mauskopf J.A., Baker C.L., Monz B.U., Juniper M.D. Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence. Journal of medical economics. 2010;13(3):403-17.
18. Christenhusz L.C., Prenger R., Pieterse M.E., Seydel E.R., van der Palen J. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients. Nicotine & tobacco research. 2011;14(6):657-63.
19. Hacıevliyagil S.S., Mutlu L.C., Gülbaş G., Yetkin Ö, Günen H. Göğüs hastalıkları servisine yatan hastaların hastane yatış maliyetlerinin karşılaştırılması. Toraks Dergisi. 2006;7(1):11-6.
20. Hilleman D.E., Dewan N., Malesker M., Friedman M. Pharmacoeconomic evaluation of COPD. CHEST Journal. 2000;118(5):1278-85.
21. Varol Y., Varol U., Başer Z., Usta L., Balcı G., Özacar R. The Cost of COPD Exacerbations Managed in Hospital. Turk Toraks Dergisi/Turkish Thoracic Journal. 2013;14(1).
22. Yıldırım F., Türk M., Öztürk C. Costs of the Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in a University Hospital. Eurasian J Pulmonol 2015; 17: 171-5
23. Toy E.L., Gallagher K.F., Stanley E.L., Swensen A.R., Duh M.S. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2010;7(3):214-28.
24. Ulubay G. Koah'lı hastalarda atak nedeni ile hastane yatışlarının maliyet analizi: Başkent Üniversitesi Ankara Hastanesi Örneği: Başkent Üniversitesi Sosyal Bilimler Enstitüsü; 2014 Ankara. Available: http://acikerisim.baskent.edu.tr/handle/11727/1525?show=full
25. Inal M.T., Memiş D., Yelken B.B., Süt N. Intensive Care Cost Analysis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Diseases from Two University Hospitals. Balkan Medical Journal. 2010;2010(5).
26. Emre J.Ç., Özdemir Ö., Baysak A., Aksoy Ü., Özdemir P., Öz A.T., et al. Clinical factors affecting the costs of hospitalized chronic obstructive pulmonary disease exacerbations. Eurasian J Pulmonol. 2014;16:180-3.
27. Tanrıverdi H. Erzincan Devlet Hastanesinde KOAH’lı hastaların doğrudan maliyet analizi. Düzce Tıp Dergisi 2013;15(2):15-8.
28. Demirtaş N., Seyfikli Z., Topçu S. Sivas bölgesinden hastanemize başvuran kadın hastalarda geleneksel biomass kullanımı ile KOAH arasındaki ilişki. Solunum Hastalıkları. 1999;10:148-55.
29. Yakışan A., Özbudak Ö., Çilli A., Öğüş C., Özdemir T. KOAH’lı kadın hastalardaki risk faktörleri. Dicle Tıp Dergisi. 2006;33(4):215-9.
30. Laurent O., Bard D., Filleul L., Segala C. Effect of socioeconomic status on the relationship between atmospheric pollution and mortality. Journal of Epidemiology & Community Health. 2007; 61(8) : 665-75.
31. Cakmak S., Dales R.E., Judek S. Respiratory health effects of air pollution gases: modification by education and income. Archives of environmental & occupational health. 2006;61(1):5-10.
32 Okutan O., Kartaloğlu Z., İlvan A., Kunter E., Cerrahoğlu K., Haznederoğlu T. KOAH'lı olgularımızın klinik ve sosyal özellikleri. Solunum. 1999;1:3-6.
33. Kartaloğlu Z., Tahaoğlu K., Ilvan A. Kronik obstrüktif akciğer hastalıklarında dispne, solunum fonksiyon testi ve genel sağlık durumu arasındaki ilişkiler. Solunum 1994; 18:539-44.
34. van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010;19(4):326-34.
35. Sethi S. Infection as a comorbidity of COPD. European Respiratory Journal. 2010;35(6):1209-15.
36. Lange P., Celli B., Agustí A., Boje Jensen G., Divo M., Faner R., et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. New England Journal of Medicine. 2015;373(2):111-22
37. Karlıkaya C., Türe M., Yıldırım E. Kronik Obstruktif Akciğer Hastalığı (KOAH) Alevlenmelerinin Mevsimsel Özelliği. Balkan Medical Journal. 2000;17(3):171-6.
38. Yu A.P., Guerin A., Ponce de Leon D., Ramakrishnan K., Wu E.Q., Mocarski M., et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. Journal of medical economics. 2011;14(4):486-96.
39. Haroon S., Adab P., Griffin C., Jordan R. Case finding for chronic obstructive pulmonary disease in primary care: a pilot randomised controlled trial. Br J Gen Pract. 2013;63(606):e55-e62.
40. Jithoo A., Enright P.L., Burney P., Buist A.S., Bateman E.D., Tan W.C., et al. Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study. European Respiratory Journal. 2013;41(3):548-55
41. Deveci F., Akpinar M., Çelikten E., Büyükşirin M., Taşdöğen N., Perim K. Effect of Noninvasive Mechanic Ventilation in Patients with Acute Respiratory Failure Due to COPD Tüberküloz ve Toraks Dergisi. 2001;49(1):28-36.
42. Göçmen H., Ediger D., Uzaslan E., Ercüment E. Stabil KOAH'lı Hastalarda Hastanede Yatış Anamnezi ile Spirometrik Değerler ve Amfizem Paterni Arasındaki İlişki. Fırat Tıp Dergisi. 2009;14(4):254-9.
43. Ozkaya S., Findik S., Atici A.G. The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease. Clinicoecon Outcomes Res 2011;3:15-8.
44. Holland A.E., Mahal A., Hill C.J., Lee A.L., Burge A.T., Moore R., et al. Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease-a multi-centre randomised controlled equivalence trial. BMC Pulm Med. 2013;13(1):57.
45. Haesum L.K., Soerensen N., Dinesen B., Nielsen C., Grann O., Hejlesen O., et al. Cost-utility analysis of a telerehabilitation program: a case study of COPD patients. Telemedicine and e-Health. 2012;18(9):688-92.
46. Sullivan S., Strassels S., Smith D. Characterization of the incidence and cost of COPD in the US. Eur Respir J. 1996;9(Supplement 23):S421.
47. Gunen H., Hacievliyagil S., Kosar F., Mutlu L., Gulbas G., Pehlivan E., et al. Factors affecting survival of hospitalised patients with COPD. European Respir J. 2005;26(2):234-41.
48. Ely E.W., Baker A.M., Evans G.W., Haponik E.F. The distribution of costs of care in mechanically ventilated patients with chronic obstructive pulmonary disease. Critical care med. 2000;28(2):408-13.
Количество просмотров: 547
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Kale Ya., Kavalcı C., Çolak T., Çelik K., Tekten B.-Ö. An analysis of clinical, demographic characteristics and costs of acute copd exacerbation patients admitted to our emergency department // Nauka i Zdravookhranenie [Science & Healthcare]. 2020, (Vol.22) 5, pp. 74-83. doi 10.34689/SH.2020.22.5.007Похожие публикации:
МЕХАНИКАЛЫҚ САРҒАЮ ОПЕРАЦИЯСЫ КЕЗІНДЕ КОАГУЛОПАТИЯЛЫҚ ҚАН КЕТУДІҢ АЛДЫН АЛУ ӘДІСІ
ОПТИМИЗАЦИЯ РЕЗУЛЬТАТОВ АУТОДЕРМОПЛАСТИКИ ПРИ ЛЕЧЕНИИ ГРАНУЛИРУЮЩИХ ГНОЙНЫХ РАН
BASICS OF REHABILITATION OF CHILDREN AFTER OPERATIONS ON THE COLON AND ANORECTAL AREA
HEALTH INDICATORS OF FIRST-YEAR-OF-LIFE CHILDREN IN THE REPUBLIC OF KAZAKHSTAN FOR 2013-2022
ОЦЕНКА УДОВЛЕТВОРЕННОСТИ ТРУДОВОЙ ДЕЯТЕЛЬНОСТЬЮ ВРАЧЕЙ АНЕСТЕЗИОЛОГОВ-РЕАНИМАТОЛОГОВ ГОРОДА АСТАНА